CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia

N Engl J Med. 2024 Apr 25;390(16):1526-1527. doi: 10.1056/NEJMe2403003.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunotherapy, Adoptive*
  • Leukemia* / therapy
  • Leukemia, Myeloid, Acute / therapy
  • Receptors, Antigen, T-Cell / therapeutic use
  • Receptors, Chimeric Antigen* / therapeutic use
  • Transplantation, Homologous*

Substances

  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen